TodayIR: Smoore International Announces Two Year Extension of Agreement with AIM ImmunoTech to Develop and Test a New Inhalation Delivery Device for Ampligen
DJ EQS-News: Smoore International Announces Two Year Extension of Agreement with AIM ImmunoTech to Develop and Test a New Inhalation Delivery Device for Ampligen EQS-News / 28/05/2021 / 09:58 UTC+8